Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Bernd Schnabl MD

Bernd Schnabl MD

Professor of Medicine, Department of Medicine, University of California San Diego, La Jolla, California

Dr. Schnabl is a trained gastroenterologist and physician-scientist. He received his MD degree from the University Freiburg in Germany. After finishing his residency in internal medicine, he completed a gastroenterology fellowship at Columbia University in New York City. He joined the Division of Gastroenterology at UC San Diego in 2008 and he is currently Professor of Medicine. He is staff physician and attending at the VA San Diego Medical Center in La Jolla and the UCSD Medical Center. He is the Director of the NIH-funded San Diego Digestive Diseases Research Center (SDDRC). His research focus is to understand the complex multi-directional interactions that occur between the gut microbiota and the liver.


Bernd Schnabl has consulted for Ferring Research Institute, HOST Therabiomics, Intercept Pharmaceuticals, Mabwell Therapeutics, Patara Pharmaceuticals, Surrozen, and Takeda. Dr. Schnabl's institution, UC San Diego, has received research support from Axial Biotherapeutics, BiomX, ChromoLogic, CymaBay Therapeutics, NGM Biopharmaceuticals, Prodigy Biotech, and Synlogic Operating Company. Dr. Schnabl is founder of Nterica Bio. UC San Diego has filed several patents with Dr. Schnabl as inventor.